Published in Hum Pathol on May 22, 2007
Methylation of an intronic region regulates miR-199a in testicular tumor malignancy. Oncogene (2011) 1.64
Errors in RNA-Seq quantification affect genes of relevance to human disease. Genome Biol (2015) 1.12
Delayed Recognition of Disorders of Sex Development (DSD): A Missed Opportunity for Early Diagnosis of Malignant Germ Cell Tumors. Int J Endocrinol (2012) 0.89
A novel SRY missense mutation affecting nuclear import in a 46,XY female patient with bilateral gonadoblastoma. Eur J Hum Genet (2009) 0.84
SRY interference of normal regulation of the RET gene suggests a potential role of the Y-chromosome gene in sexual dimorphism in Hirschsprung disease. Hum Mol Genet (2014) 0.81
TSPY and Male Fertility. Genes (Basel) (2010) 0.79
Transgenic Mouse Studies to Understand the Regulation, Expression and Function of the Testis-Specific Protein Y-Encoded (TSPY) Gene. Genes (Basel) (2010) 0.79
Roles of the Y chromosome genes in human cancers. Asian J Androl (2015) 0.78
Hypermethylation of genes in testicular embryonal carcinomas. Br J Cancer (2015) 0.77
Intratubular transplantation as a strategy for establishing animal models of testicular germ cell tumours. Int J Exp Pathol (2008) 0.76
Long-term vitamin A deficiency induces alteration of adult mouse spermatogenesis and spermatogonial differentiation: direct effect on spermatogonial gene expression and indirect effects via somatic cells. J Nutr Biochem (2012) 0.76
Gonadoblastoma with Dysgerminoma in a Phenotypically Turner-Like Girl with 45,X/46,XY Karyotype. J Clin Res Pediatr Endocrinol (2015) 0.75
Testicular biopsy in prepubertal boys: a worthwhile minor surgical procedure? Nat Rev Urol (2016) 0.75
The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature (2003) 12.44
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell (2006) 11.01
Mammalian cyclin-dependent kinases. Trends Biochem Sci (2005) 5.54
Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol (2005) 4.80
From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol (2004) 4.72
Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer (2005) 3.75
Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res (2005) 3.23
Gonadoblastoma. A review of 74 cases. Cancer (1970) 2.45
Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenet (1987) 2.10
Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res (2006) 1.94
Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update (2006) 1.87
FoxM1 dances with mitosis. Nat Cell Biol (2005) 1.85
A concise review of DNA damage checkpoints and repair in mammalian cells. Cardiovasc Revasc Med (2006) 1.66
Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet (1996) 1.65
Molecular isolation and characterization of an expressed gene from the human Y chromosome. Hum Mol Genet (1992) 1.56
Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma. Stem Cells (2004) 1.56
Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development (1987) 1.49
Germ cell cancer and disorders of spermatogenesis: an environmental connection? APMIS (1998) 1.47
Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol (2004) 1.47
Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. Cancer Res (2006) 1.41
Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol (2005) 1.36
Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. Hum Reprod (2004) 1.34
New insights into testicular germ cell tumorigenesis from gene expression profiling. Cancer Res (2002) 1.25
The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS (2003) 1.24
Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours. J Pathol (2005) 1.22
Gonadoblastoma: molecular definition of the susceptibility region on the Y chromosome. Am J Hum Genet (1995) 1.22
Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads. J Clin Endocrinol Metab (2006) 1.19
12p-amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH. Oncogene (2003) 1.18
Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies. Carcinogenesis (2005) 1.17
Gonadoblastoma; a gonadal tumor related to the dysgerminoma (seminoma) and capable of sex-hormone production. Cancer (1953) 1.12
Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review. Ann Oncol (2005) 1.11
Expression analysis of thirty one Y chromosome genes in human prostate cancer. Mol Carcinog (2000) 1.11
New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers. J Pathol (2006) 1.09
Gonadoblastoma, testicular and prostate cancers, and the TSPY gene. Am J Hum Genet (1999) 1.08
TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer (2006) 1.07
Molecular mapping of the putative gonadoblastoma locus on the Y chromosome. Genes Chromosomes Cancer (1995) 1.06
Carcinoma in situ in the testis. Scand J Urol Nephrol Suppl (2000) 1.05
Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes. J Clin Endocrinol Metab (2005) 1.04
Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS (1998) 1.04
A Cre gene directed by a human TSPY promoter is specific for germ cells and neurons. Genesis (2005) 1.03
Role of gain of 12p in germ cell tumour development. APMIS (2003) 1.01
Application of transcriptional and biological network analyses in mouse germ-cell transcriptomes. Genomics (2006) 1.01
Expression of a candidate gene for the gonadoblastoma locus in gonadoblastoma and testicular seminoma. Cytogenet Cell Genet (2000) 0.98
Chromosomes, genes, and development of testicular germ cell tumors. Cancer Genet Cytogenet (2004) 0.96
Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer. Cytogenet Genome Res (2003) 0.92
Y chromosome sequences in Turner's syndrome: association with virilization and gonadoblastoma. J Pediatr Endocrinol Metab (2003) 0.92
Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. Biochim Biophys Acta (2005) 0.91
Gonadoblastoma in Turner syndrome and Y-chromosome-derived material. Am J Med Genet A (2005) 0.89
The poly(ADP-ribose) polymerase 1 interacts with Sry and modulates its biological functions. Mol Cell Endocrinol (2006) 0.89
Mouse models of cell cycle regulators: new paradigms. Results Probl Cell Differ (2006) 0.88
Germ cell lineage differentiation in non-seminomatous germ cell tumours. J Pathol (2006) 0.87
Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells. Histopathology (1997) 0.87
Rewiring the exit from mitosis. Cell Cycle (2005) 0.86
Pathobiology of testicular germ cell tumors: views and news. Anal Quant Cytol Histol (2002) 0.84
Detection of TSPY protein in a unilateral microscopic gonadoblastoma of a Turner mosaic patient with a Y-derived marker chromosome. J Pathol (1999) 0.84
TSPY variants in six loci on the human Y chromosome. Cytogenet Cell Genet (2000) 0.80
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell (2006) 11.01
Lung cancer: intragenic ERBB2 kinase mutations in tumours. Nature (2004) 8.35
Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res (2005) 7.66
A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. Nat Genet (2005) 6.70
Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer (2005) 3.75
Noninvasive detection of testicular carcinoma in situ in semen using OCT3/4. Eur Urol (2007) 3.34
Sequence analysis of the protein kinase gene family in human testicular germ-cell tumors of adolescents and adults. Genes Chromosomes Cancer (2006) 2.50
Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev (2006) 2.40
Role of P53 and MDM2 in treatment response of human germ cell tumors. J Clin Oncol (2002) 2.36
The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet (2005) 2.26
Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors. J Clin Oncol (2009) 2.11
Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magn Reson Med (2006) 2.04
Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated to seminomas. Oncogene (2002) 2.03
Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes. Immunity (2010) 2.00
Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med (2003) 1.89
Germ cell survival through carbohydrate-mediated interaction with Sertoli cells. Science (2002) 1.87
Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magn Reson Med (2008) 1.69
Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. Clin Cancer Res (2011) 1.68
The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency. Proc Natl Acad Sci U S A (2009) 1.59
CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat Biotechnol (2006) 1.58
Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor. Int J Cancer (2010) 1.58
Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype. Prostate (2005) 1.57
Sialyl Lewis X-dependent lung colonization of B16 melanoma cells through a selectin-like endothelial receptor distinct from E- or P-selectin. Cancer Res (2002) 1.55
The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer (2005) 1.51
MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis (2011) 1.51
Testicular microlithiasis in boys and young men with congenital or acquired undescended (ascending) testis. J Urol (2010) 1.48
Enhancement of human sperm motility by trophinin binding peptide. J Urol (2008) 1.48
Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol (2004) 1.47
Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer (2002) 1.45
Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine. Cancer (2005) 1.45
Lessons from human teratomas to guide development of safe stem cell therapies. Nat Biotechnol (2012) 1.43
The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men. J Urol (2006) 1.43
Histopathological and molecular features of late relapses in non-seminomas. BJU Int (2010) 1.40
DNA methylation of cancer genome. Birth Defects Res C Embryo Today (2009) 1.39
Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol (2005) 1.36
Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PLoS One (2012) 1.35
Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features. Cancer (2003) 1.32
Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase. Proc Natl Acad Sci U S A (2009) 1.32
Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach. Glycobiology (2007) 1.31
MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS One (2013) 1.27
Up-regulation of microRNA-21 correlates with lower kidney cancer survival. PLoS One (2012) 1.26
Critical function of AP-2 gamma/TCFAP2C in mouse embryonic germ cell maintenance. Biol Reprod (2009) 1.26
Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy. Magn Reson Med (2008) 1.25
Serial analysis of gene expression in adrenocortical hyperplasia caused by a germline PRKAR1A mutation. J Clin Endocrinol Metab (2005) 1.25
Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance. J Pathol (2010) 1.24
Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Res (2005) 1.23
Downregulation of metastasis suppressor genes in malignant pheochromocytoma. Int J Cancer (2005) 1.23
Why human extragonadal germ cell tumours occur in the midline of the body: old concepts, new perspectives. Int J Androl (2007) 1.22
Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients. Transplantation (2004) 1.22
Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours. J Pathol (2005) 1.22
Expression profiling during ocular development identifies 2 Nlz genes with a critical role in optic fissure closure. Proc Natl Acad Sci U S A (2009) 1.22
Analysis of mouse germ-cell transcriptome at different stages of spermatogenesis by SAGE: biological significance. Genomics (2004) 1.20
New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD). Mol Cell Endocrinol (2008) 1.19
Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads. J Clin Endocrinol Metab (2006) 1.19
A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans. EMBO J (2011) 1.18
12p-amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH. Oncogene (2003) 1.18
Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus. Gut (2012) 1.18
MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer. Carcinogenesis (2011) 1.16
Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer. PLoS One (2013) 1.16
Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future. Crit Rev Oncog (2006) 1.16
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Adv Exp Med Biol (2007) 1.15
MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer. PLoS One (2012) 1.11
Transcriptome analyses of male germ cells with serial analysis of gene expression (SAGE). Mol Cell Endocrinol (2006) 1.09
Further characterization of the first seminoma cell line TCam-2. Genes Chromosomes Cancer (2008) 1.09
The molecular signature of spermatogonial stem/progenitor cells in the 6-day-old mouse testis. Biol Reprod (2008) 1.09
Basal cell carcinoma does metastasize. Dermatol Online J (2008) 1.08
Expression of BLIMP1/PRMT5 and concurrent histone H2A/H4 arginine 3 dimethylation in fetal germ cells, CIS/IGCNU and germ cell tumors. BMC Dev Biol (2008) 1.08
Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression. Glycobiology (2005) 1.08
Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4. Mol Cancer Ther (2011) 1.07
The complexity of antisense transcription revealed by the study of developing male germ cells. Genomics (2006) 1.07
TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer (2006) 1.07
Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer (2005) 1.06
Core3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma PC3 and LNCaP cells through down-regulation of alpha2beta1 integrin complex. J Biol Chem (2009) 1.06
Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein. Biol Reprod (2004) 1.05
Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy. NMR Biomed (2009) 1.05
Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151. PLoS One (2012) 1.05
Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes. J Clin Endocrinol Metab (2005) 1.04
Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma. Mol Carcinog (2011) 1.04
Polymorphisms in prostate-specific antigen (PSA) gene, risk of prostate cancer, and serum PSA levels in Japanese population. Cancer Lett (2003) 1.04
Wnt antagonist gene polymorphisms and renal cancer. Cancer (2009) 1.04
Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation. Int J Cancer (2009) 1.04
Genetic aspects of testicular germ cell tumors. Cell Cycle (2008) 1.04
Molecular determinants of treatment response in human germ cell tumors. Clin Cancer Res (2003) 1.03
A Cre gene directed by a human TSPY promoter is specific for germ cells and neurons. Genesis (2005) 1.03
Expression profiling of purified male germ cells: stage-specific expression patterns related to meiosis and postmeiotic development. Physiol Genomics (2005) 1.02
Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study. Int J Clin Oncol (2012) 1.02
Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer. Cancer Res (2003) 1.01
Application of transcriptional and biological network analyses in mouse germ-cell transcriptomes. Genomics (2006) 1.01
Regulation of monoamine oxidase A by the SRY gene on the Y chromosome. FASEB J (2009) 1.00